Advertisement

Pathologie pp 337-376 | Cite as

Tumoren und tumorartige Erkrankungen der Milz

  • Jacques Diebold
  • Thomas Rüdiger
  • Alexander Marx
  • Hans Konrad Müller-Hermelink
Chapter

Zusammenfassung

In diesem Kapitel werden die den verschiedenen Gewebskomponenten des Organs zugeordneten Tumoren und tumorartigen Alterationen mit ihren makroskopischen und histopathologischen Befunden dargestellt. Nach einer Diskussion der zystischen Milzläsionen folgt eine detaillierte Darstellung gutartiger und maligner vaskulärer Tumoren in ihren charakteristischen und milztypischen Befunden. Das große Kapitel der speziellen hämatologischen Tumoren der Milz und des Organbefalls bei systemischen malignen Lymphomen wird auf dem Boden der neuen WHO diskutiert, wobei auch auf die heute historischen Befunde aus der Zeit, als therapeutische und diagnostische Splenektomien noch häufiger waren, zurückgegriffen werden kann. Schließlich folgt die Darstellung unterschiedlicher histiozytärer Tumoren in der Milz und die Diskussion von Milzmetastasen.

Literatur

  1. 1.
    Abbott RM, Levy AD, Aguilera NS et al (2004) From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics 24:1137–1163CrossRefGoogle Scholar
  2. 2.
    Agnarsson BA, Loughran TP Jr, Starkebaum G et al (1989) The pathology of large granular lymphocyte leukemia. Hum Pathol 20:643–651CrossRefGoogle Scholar
  3. 3.
    Algara P, Mateo MS, Sanchez-Beato M et al (2002) Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 99:1299–1304CrossRefGoogle Scholar
  4. 4.
    Alkan S, Ross CW, Hanson CA et al (1996) Follicular lymphoma with involvement of the splenic marginal zone: a pitfall in the differential diagnosis of splenic marginal zone cell lymphoma. Hum Pathol 27:503–506CrossRefGoogle Scholar
  5. 5.
    Al-Mansour M, Connors JM, Gascoyne RD et al (2010) Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin’s lymphoma. J Clin Oncol 28:793–799CrossRefGoogle Scholar
  6. 6.
    Anoun S, Marouane S, Quessar A et al (2014) Primary splenic angiosarcoma revealed by bone marrow metastasis (kemik iligi metastazi ile aciga cikan primer splenik anjiosarkom). Turk J Haematol 31:408–410CrossRefGoogle Scholar
  7. 7.
    Arber DA, Strickler JG, Chen YY et al (1997) Splenic vascular tumors: a histologic, immunophenotypic, and virologic study. Am J Surg Pathol 21:827–835CrossRefGoogle Scholar
  8. 8.
    Arber DA, Strickler JG, Weiss LM (1997) Splenic mesothelial cysts mimicking lymphagiomas. Am J Surg Pathol 21:334–338CrossRefGoogle Scholar
  9. 9.
    Arons E, Suntum T, Stetler-Stevenson M et al (2009) VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood 114:4687–4695CrossRefGoogle Scholar
  10. 10.
    Audouin J, Le Tourneau A, Molina T et al (2003) Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. Br J Haematol 122:404–412CrossRefGoogle Scholar
  11. 11.
    Bahler DW, Pindzola JA, Swerdlow SH (2002) Splenic marginal zone lymphomas appear to originate from different B cell types. Am J Pathol 161:81–88CrossRefGoogle Scholar
  12. 12.
    Baseggio L, Gazzo S, Callet-Bauchu E et al (2005) An unusual case of indolent B-cell lymphoma with distinct chronic lymphocytic leukemia and marginal zone differentiation according to the site of involvement. Leuk Lymphoma 46:1369–1374CrossRefGoogle Scholar
  13. 13.
    Belhadj K, Reyes F, Farcet J et al (2003) Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102:4261–4269CrossRefGoogle Scholar
  14. 14.
    Ben-Izhak O, Bejar J, Ben-Eliezer S et al (2001) Splenic littoral cell haemangioendothelioma: a new low-grade variant of malignant littoral cell tumour. Histopathology 39:469–475CrossRefGoogle Scholar
  15. 15.
    Bisceglia M, Sickel JZ, Giangaspero F et al (1998) Littoral cell angioma of the spleen: an additional report of four cases with emphasis on the association with visceral organ cancers. Tumori 84:595–599CrossRefGoogle Scholar
  16. 16.
    Boudova L, Torlakovic E, Delabie J et al (2003) Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 102:3753–3758CrossRefGoogle Scholar
  17. 17.
    Bouroncle BA (1994) Thirty-five years in the progress of hairy cell leukemia. Leuk Lymphoma 14(Suppl 1):1–12PubMedGoogle Scholar
  18. 18.
    Braggio E, Dogan A, Keats JJ et al (2012) Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol 25:651–660CrossRefGoogle Scholar
  19. 19.
    Bürrig KF (1988) Epithelial (true) splenic cysts. Pathogenesis of the mesothelial and so-called epidermoid cyst of the spleen. Am J Surg Pathol 12:275–281CrossRefGoogle Scholar
  20. 20.
    Camacho FI, Mollejo M, Mateo MS et al (2001) Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Am J Surg Pathol 25:1268–1276CrossRefGoogle Scholar
  21. 21.
    Capello D, Vitolo U, Pasqualucci L et al (2000) Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 95:651–659PubMedGoogle Scholar
  22. 22.
    Cawley JC, Burns GF, Hayhoe FG (1980) A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia. Leuk Res 4:547–559CrossRefGoogle Scholar
  23. 23.
    Chan JKC (2003) Splenic involvement by peripheral T-cell and NK-cell neoplasms. Semin Diagn Pathol 20:105–120CrossRefGoogle Scholar
  24. 24.
    Choe J, Go H, Jeon YK et al (2013) Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the spleen: a report of six cases with increased IgG4-positive plasma cells. Pathol Int 63:245–251CrossRefGoogle Scholar
  25. 25.
    Cook AM, Graham JD (1996) Spontaneous rupture of the spleen secondary to metastatic teratoma. J R Soc Med 89:710CrossRefGoogle Scholar
  26. 26.
    Cooke CB, Krenacs L, Stetler-Stevenson M et al (1996) Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 88:4265–4274PubMedGoogle Scholar
  27. 27.
    Dekeyzer S, Houthoofd B, de Potter A et al (2013) Hemangiomatosis of the spleen in a patient with Klippel-trenaunay syndrome. JBR-BTR 96:357–359PubMedGoogle Scholar
  28. 28.
    Delarue J, Diebold J (1971) The spleen in Hodgkin’s disease. Anatomico-pathological study following splenectomy (La rate dans la maladie de Hodgkin. Etude anatomo-pathologique apres splenectomie). Virchows Arch A Pathol Pathol Anat 353:27–44CrossRefGoogle Scholar
  29. 29.
    Despoina M, Dionysios D, Georgios A et al (2014) Primary angiosarcoma of the spleen: an oncological enigma. Case Rep Oncol Med 2014:193036PubMedPubMedCentralGoogle Scholar
  30. 30.
    Dierlamm J, Stefanova M, Wlodarska I et al (2000) Analysis of the P53, RB/D13S25, and P16 tumor suppressor genes in marginal zone B-cell lymphoma: An interphase fluorescence in situ hybridization study. Cancer Genet Cytogenet 120:1–5CrossRefGoogle Scholar
  31. 31.
    Dufau JP, Le Tourneau A, Audouin J et al (1999) Isolated diffuse hemangiomatosis of the spleen with Kasabach-Merritt-like syndrome. Histopathology 35:337–344CrossRefGoogle Scholar
  32. 32.
    Duong Van Huyen JP, Molina T, Delmer A et al (2000) Splenic marginal zone lymphoma with or without plasmacytic differentiation. Am J Surg Pathol 24:1581–1592CrossRefGoogle Scholar
  33. 33.
    Easler RE, Dowlin WM (1969) Primary lipoma of the spleen. Report of a case. Arch Pathol 88:557–559PubMedGoogle Scholar
  34. 34.
    Eyre TA, Gatter K, Collins GP et al (2015) Incidence, management and outcome of high grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experience. Am J Hematol 90:E103–110CrossRefGoogle Scholar
  35. 35.
    Falk S, Krishnan J, Meis JM (1993) Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases. Am J Surg Pathol 17:959–970CrossRefGoogle Scholar
  36. 36.
    Falk S, Stutte HJ, Frizzera G (1991) Littoral cell angioma. A novel splenic vascular lesion demonstrating histiocytic differentiation. Am J Surg Pathol 15:1023–1033CrossRefGoogle Scholar
  37. 37.
    Fernandez S, Cook GW, Arber DA (2006) Metastasizing splenic littoral cell hemangioendothelioma. Am J Surg Pathol 30:1036–1040CrossRefGoogle Scholar
  38. 38.
    Fodor A, Molnar MZ, Krenacs L et al (2009) Autoimmune hemolytic anemia as a risk factor of poor outcome in patients with splenic marginal zone lymphoma. Pathol Oncol Res 15:597–603CrossRefGoogle Scholar
  39. 39.
    Geissinger E, Odenwald T, Lee S et al (2004) Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert’s) variant are often derived from CD8(+) cytotoxic T-cells. Virchows Arch 445:334–343CrossRefGoogle Scholar
  40. 40.
    Haedicke W, Ho FC, Chott A et al (2000) Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood 95:3628–3630PubMedGoogle Scholar
  41. 41.
    Harada S, Kalla H, Balasubramanian M et al (2008) Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen. Ann Diagn Pathol 12:212–216CrossRefGoogle Scholar
  42. 42.
    Heintel D, Streubel B, Welzel N et al (2003) Burkitt lymphoma following splenic marginal zone lymphoma. evidence for two independent B-cell clones. Cancer Genet Cytogenet 141:86–88CrossRefGoogle Scholar
  43. 43.
    Herling M, Khoury JD, Washington LT et al (2004) A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 104:328–335CrossRefGoogle Scholar
  44. 44.
    Hermine O, Lefrere F, Bronowicki J et al (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347:89–94CrossRefGoogle Scholar
  45. 45.
    Ioannidis I, Kahn AG (2015) Splenic lymphangioma. Arch Pathol Lab Med 139:278–282CrossRefGoogle Scholar
  46. 46.
    Isaacson PG, Matutes E, Burke M et al (1994) The histopathology of splenic lymphoma with villous lymphocytes. Blood 84:3828–3834PubMedGoogle Scholar
  47. 47.
    Jain P, Pemmaraju N, Ravandi F (2014) Update on the biology and treatment options for hairy cell leukemia. Curr Treat Options Oncol 15:187–209CrossRefGoogle Scholar
  48. 48.
    Kawachi K, Nakatani Y, Inayama Y et al (2002) Interdigitating dendritic cell sarcoma of the spleen: report of a case with a review of the literature. Am J Surg Pathol 26:530–537CrossRefGoogle Scholar
  49. 49.
    Kiel MJ, Velusamy T, Rolland D et al (2014) Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. Blood 124:1460–1472CrossRefGoogle Scholar
  50. 50.
    Konig EA, Kusser WC, Day C et al (2000) p53 mutations in hairy cell leukemia. Leukemia 14:706–711CrossRefGoogle Scholar
  51. 51.
    Kornmann V, van Rijn P, Mulder D et al (2015) Delayed diagnosis of angiosarcoma of the spleen: clinically presenting as recurrent haemoperitoneum following embolisation. BMJ Case Rep 2015:bcr2014208956CrossRefGoogle Scholar
  52. 52.
    Kraus MD, Fleming MD, Vonderheide RH (2001) The spleen as a diagnostic specimen: a review of 10 years’ experience at two tertiary care institutions. Cancer 91:2001–2009CrossRefGoogle Scholar
  53. 53.
    Kutok JL, Fletcher CDM (2003) Splenic vascular tumors. Semin Diagn Pathol 20:128–139CrossRefGoogle Scholar
  54. 54.
    Lam KY, Chan AC, Wat MS (1996) Langerhans cell histiocytosis forming an asymptomatic solitary nodule in the spleen. J Clin Pathol 49:262–264CrossRefGoogle Scholar
  55. 55.
    Larsen BT, Bishop MC, Hunter GC et al (2013) Low-grade, metastasizing splenic littoral cell angiosarcoma presenting with hepatic cirrhosis and splenic artery aneurysm. Int J Surg Pathol 21:618–626CrossRefGoogle Scholar
  56. 56.
    Lefebvre C, Fabre B, Vettier C et al (2007) Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones. Hum Pathol 38:660–667CrossRefGoogle Scholar
  57. 57.
    Li S, Mann KP, Holden JT (2004) T-cell-rich B-cell lymphoma presenting in the spleen: a clinicopathologic analysis of 3 cases. Int J Surg Pathol 12:31–37CrossRefGoogle Scholar
  58. 58.
    Li X, Cheuk W, Lam PWY et al (2014) Inflammatory pseudotumor-like follicular dendritic cell tumor of liver and spleen: granulomatous and eosinophil-rich variants mimicking inflammatory or infective lesions. Am J Surg Pathol 38:646–653CrossRefGoogle Scholar
  59. 59.
    Lima M, Almeida J, Dos Anjos Teixeira M et al (2003) TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder. Am J Pathol 163:763–771CrossRefGoogle Scholar
  60. 60.
    Manoj MG, Misra P, Kakkar S (2012) Multilocular epithelial cyst of spleen: a rare occurrence. Indian J Pathol Microbiol 55:602–604CrossRefGoogle Scholar
  61. 61.
    Mateo M, Mollejo M, Villuendas R et al (1999) 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 154:1583–1589CrossRefGoogle Scholar
  62. 62.
    Matutes E, Brito-Babapulle V, Swansbury J et al (1991) Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78:3269–3274PubMedGoogle Scholar
  63. 63.
    Matutes E, Garcia Talavera J, O’Brien M et al (1986) The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol 64:111–124CrossRefGoogle Scholar
  64. 64.
    Mollejo M, Algara P, Mateo MS et al (2002) Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma? Histopathology 40:22–30CrossRefGoogle Scholar
  65. 65.
    Mollejo M, Algara P, Mateo MS et al (2003) Large B-cell lymphoma presenting in the spleen: identification of different clinicopathologic conditions. Am J Surg Pathol 27:895–902CrossRefGoogle Scholar
  66. 66.
    Mollejo M, Lloret E, Menarguez J et al (1997) Lymph node involvement by splenic marginal zone lymphoma: morphological and immunohistochemical features. Am J Surg Pathol 21:772–780CrossRefGoogle Scholar
  67. 67.
    Mori T, Fukutomi K, Kato Y et al (1999) 1998 results of the first series of follow-up studies on Japanese thorotrast patients and their relationships to an autopsy series. Radiat Res 152(Suppl):S72–S80CrossRefGoogle Scholar
  68. 68.
    Natsume H, Yamaguchi T, Ohsawa J et al (2005) Splenic infarction in Letterer–Siwe disease. Pediatr Int 47:329–332CrossRefGoogle Scholar
  69. 69.
    Neuhauser TS, Derringer GA, Thompson LD et al (2000) Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases. Mod Pathol 13:978–987CrossRefGoogle Scholar
  70. 70.
    Notoya A, Bohgaki T, Mukai M et al (2000) Splenomegaly and chronic disseminated intravascular coagulation in Osler-Weber-Rendu disease: a case report. Am J Hematol 65:315–318CrossRefGoogle Scholar
  71. 71.
    O’Malley DP, Kim YS, Perkins SL et al (2005) Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders. Mod Pathol 18:1550–1561CrossRefGoogle Scholar
  72. 72.
    Osuji N, Matutes E, Catovsky D et al (2005) Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review. Am J Surg Pathol 29:935–941CrossRefGoogle Scholar
  73. 73.
    Palmieri I, Natale E, Crafa F et al (2005) Epithelial splenic cysts. Anticancer Res 25(1B):515–521PubMedGoogle Scholar
  74. 74.
    Papadaki T, Stamatopoulos K, Kosmas C et al (2003) A unique case of splenic marginal zone-cell lymphoma with synchronous clonal T-cell large granular lymphocyte proliferation: an immunologic, immunohistochemical and genotypic study. Leuk Res 27:85–87CrossRefGoogle Scholar
  75. 75.
    Papke J, Radke EU (1990) Primäres malignes Teratom der Milz. Z Gesamte Inn Med 45:172–174PubMedGoogle Scholar
  76. 76.
    Piris MA, Mollejo M, Campo E et al (1998) A marginal zone pattern may be found in different varieties of non-Hodgkin’s lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma. Histopathology 33:230–239CrossRefGoogle Scholar
  77. 77.
    Reuter S, Seitz HM, Kern P et al (2000) Extrahepatic alveolar echinococcosis without liver involvement: a rare manifestation. Infection 28:187–192CrossRefGoogle Scholar
  78. 78.
    Robledo C, Garcia JL, Benito R et al (2011) Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas. PLoS ONE 6:e24939CrossRefGoogle Scholar
  79. 79.
    Rosenbaum L, Fekrazad MH, Rabinowitz I et al (2009) Epstein-Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature. J Hematop 2:127–131CrossRefGoogle Scholar
  80. 80.
    Ruck P, Horny HP, Xiao JC et al (1994) Diffuse sinusoidal hemangiomatosis of the spleen. A case report with enzyme-histochemical, immunohistochemical, and electron-microscopic findings. Pathol Res Pract 190:708–714 (discussion 715–717)CrossRefGoogle Scholar
  81. 81.
    Sarandria JJ, Escano M, Kamangar F et al (2014) Massive splenomegaly correlates with malignancy: 180 cases of splenic littoral cell tumors in the world literature. Minerva Chir 69:229–237PubMedGoogle Scholar
  82. 82.
    Sarode VR, Datta BN, Savitri K et al (1991) Kaposi’s sarcoma of spleen with unusual clinical and histologic features. Arch Pathol Lab Med 115:1042–1044PubMedGoogle Scholar
  83. 83.
    Schmid C, Kirkham N, Diss T et al (1992) Splenic marginal zone cell lymphoma. Am J Surg Pathol 16:455–466CrossRefGoogle Scholar
  84. 84.
    Schott P, Kurtz B (2011) Lipom der Milz (Lipom der Milz). Rofo 183:857–858CrossRefGoogle Scholar
  85. 85.
    Sharpe RW, Bethel KJ (2006) Hairy cell leukemia: diagnostic pathology. Hematol Oncol Clin North Am 20:1023–1049CrossRefGoogle Scholar
  86. 86.
    Sordillo EM, Sordillo PP, Hajdu SI (1995) Splenic angiosarcoma. Am J Surg Pathol 19:119–120CrossRefGoogle Scholar
  87. 87.
    Thieblemont C, Davi F, Noguera M et al (2012) Splenic marginal zone lymphoma: current knowledge and future directions. Oncol (willist Park 26:194–202Google Scholar
  88. 88.
    Traverse-Glehen A, Bachy E, Baseggio L et al (2013) Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases. Histopathology 62:876–893CrossRefGoogle Scholar
  89. 89.
    van Krieken JH (1990) Histopathology of the spleen in non-Hodgkin’s lymphoma. Histol Histopathol 5:113–122PubMedGoogle Scholar
  90. 90.
    van Krieken JH, Feller AC, Te Velde J (1989) The distribution of non-Hodgkin’s lymphoma in the lymphoid compartments of the human spleen. Am J Surg Pathol 13:757–765CrossRefGoogle Scholar
  91. 91.
    Wang C, Rabah R, Blackstein M et al (2004) Bone marrow metastasis of angiosarcoma. Pathol Res Pract 200:551–555CrossRefGoogle Scholar
  92. 92.
    Wang SA, Olson N, Zukerberg L et al (2006) Splenic marginal zone lymphoma with micronodular T-cell rich B-cell lymphoma. Am J Surg Pathol 30:128–132CrossRefGoogle Scholar
  93. 93.
    Waterfall JJ, Arons E, Walker RL et al (2014) High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias. Nat Genet 46:8–10CrossRefGoogle Scholar
  94. 94.
    Went PT, Zimpfer A, Pehrs A et al (2005) High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia. Am J Surg Pathol 29:474–478CrossRefGoogle Scholar
  95. 95.
    Willcox TM, Speer RW, Schlinkert RT et al (2000) Hemangioma of the spleen: presentation, diagnosis, and management. J Gastrointest Surg 4:611–613CrossRefGoogle Scholar
  96. 96.
    Xi L, Arons E, Navarro W et al (2012) Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood 119:3330–3332CrossRefGoogle Scholar
  97. 97.
    Yamada S, Tasaki T, Satoh N et al (2012) Primary splenic histiocytic sarcoma complicated with prolonged idiopathic thrombocytopenia and secondary bone marrow involvement: a unique surgical case presenting with splenomegaly but non-nodular lesions. Diagn Pathol 7:143CrossRefGoogle Scholar
  98. 98.
    Zwi LJ, Evans DJ, Wechsler AL et al (1986) Splenic angiosarcoma following chemotherapy for follicular lymphoma. Hum Pathol 17:528–530CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Jacques Diebold
    • 1
  • Thomas Rüdiger
    • 2
  • Alexander Marx
    • 3
  • Hans Konrad Müller-Hermelink
    • 4
  1. 1.ParisFrankreich
  2. 2.Städt. Klinikum KarlsruheKarlsruheDeutschland
  3. 3.Institut für PathologieUniversitätsmedizin Mannheim der Universität HeidelbergMannheimDeutschland
  4. 4.Pathologisches Institut der Universität WürzburgWürzburgDeutschland

Personalised recommendations